Patent Assignment
Reel/Frame 058532/0041
Assignment of Assignor's Interest
Recorded: 2021-12-16
Pages: 4
Assignors
ST PHI THERAPEUTICS
Executed: 2021-11-03
YIZUN BIOTECH (SHANGHAI) CO., LTD
Executed: 2021-11-03
Assignee
YIZUN BIOPHARM (SHANGHAI) CO., LTD
ROOM 714, BUILDING 3, 111 XIANGKE ROAD, SHANGHAI, CHINA
Covered Properties
(3)
Chimeric Endocytic Receptors and Method of Use Thereof
Chimeric Natural Killer Cell Receptors and Method of Using Thereof
Application:
16/827,697 →
Publication:
US 2020/0308248
Universal T Cells and the Method of Use Thereof
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 9, 2020
From: LIU, STEVEN LINGFENG; ZHONG, WENTING
To: ST PHI THERAPEUTICS; YIZUN BIOTECH (SHANGHAI) CO., LTD; YIZUN BIOPHARM (SHANGHAI) CO., LTD
Reel/Frame 052058/0305 →
Assignment of Assignor's Interest
Mar 23, 2020
From: LIU, STEVEN LINGFENG; ZHONG, WENTING
To: ST PHI THERAPEUTICS; YIZUN BIOTECH (SHANGHAI) CO., LTD; YIZUN BIOPHARM (SHANGHAI) CO., LTD
Reel/Frame 052200/0242 →
Change of Name
Mar 23, 2023
From: YIZUN BIOPHARM (SHANGHAI) CO., LTD
To: ST PHI THERAPEUTICS CO., LTD.
Reel/Frame 063068/0134 →